F-Prime Capital Partners

Suggest edits

Follow us

Also headquartered in Cambridge

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 63

Portfolio

Portfolio Tracker

People

Add info

Checkmate Pharmaceuticals (CMPI) Stock: Why The Price Increased Over 320% Today

Apellis Pharma eyes a shot at getting first FDA approval in rare vision disorder

Orchard Therapeutics Stock (ORTX): $9 Price Target From Cantor Fitzgerald

Caribou Biosciences (CRBU) Stock: $28 Price Target From H.C. Wainwright

Adagene (ADAG) Stock: Why The Price Increased Today

Hotel business intelligence platform OTA Insight nabs $80M

$100,000,000 Venture capital (Series B)

Notable aims to improve AI in health care with new $100M

Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics

$10,900,000 Venture capital (Series A)

Robotics Company Burro Closes $10.9 Million

Former Iora Health execs raise $13M to guide seniors through Medicare enrollment

CRISPR biotech Caribou Biosciences’ IPO reels in $304M for next-gen cell therapy

$80,000,000 Venture capital (Series D)

Cancer Drugmaker Turnstone Biologics Raises $80 Million

Protenus and UC Davis Health Present at HIMSS21 on Leveraging Artificial Intelligence to Reduce …

$21,000,000 Venture capital (Series D)

Baltimore healthcare analytics company Protenus raises $21M in Series D round

$2,100,000,000

One Medical (ONEM) Announces Deal To Buy Iora Health In $2.1 Billion Deal: Details

PE-backed Appriss Health acquires PatientPing

$22,500,000 Venture capital (Series C)

Dental platform CareStack gets funding from existing investors in extended round

Notable Health seeks to improve COVID-19 vaccine administration through intelligent automation

$34,000,000 Venture capital (Series B)

Index

By TNW

F-Prime Capital Partners

F-Prime Capital Partners

Overview

News

Investments 63

Portfolio

Portfolio Tracker

People

Checkmate Pharmaceuticals (CMPI) Stock: Why The Price Increased Over 320% Today

Apellis Pharma eyes a shot at getting first FDA approval in rare vision disorder

Orchard Therapeutics Stock (ORTX): $9 Price Target From Cantor Fitzgerald

Caribou Biosciences (CRBU) Stock: $28 Price Target From H.C. Wainwright

Adagene (ADAG) Stock: Why The Price Increased Today

Hotel business intelligence platform OTA Insight nabs $80M

Notable aims to improve AI in health care with new $100M

Sana Biotechnology inks $50M deal for precise gene editing system from Beam Therapeutics

Robotics Company Burro Closes $10.9 Million

Former Iora Health execs raise $13M to guide seniors through Medicare enrollment

CRISPR biotech Caribou Biosciences’ IPO reels in $304M for next-gen cell therapy

Cancer Drugmaker Turnstone Biologics Raises $80 Million

Protenus and UC Davis Health Present at HIMSS21 on Leveraging Artificial Intelligence to Reduce …

Baltimore healthcare analytics company Protenus raises $21M in Series D round

One Medical (ONEM) Announces Deal To Buy Iora Health In $2.1 Billion Deal: Details

PE-backed Appriss Health acquires PatientPing

Dental platform CareStack gets funding from existing investors in extended round

Notable Health seeks to improve COVID-19 vaccine administration through intelligent automation

Digital Health Plan Company Centivo Raises $34 Million

Chinese biotech firm Adagene plans $200m US IPO